BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10671201)

  • 1. The BOB.1 / OBF.1 co-activator is essential for octamer-dependent transcription in B cells.
    Laumen H; Nielsen PJ; Wirth T
    Eur J Immunol; 2000 Feb; 30(2):458-69. PubMed ID: 10671201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development.
    Hess J; Nielsen PJ; Fischer KD; Bujard H; Wirth T
    Mol Cell Biol; 2001 Mar; 21(5):1531-9. PubMed ID: 11238890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice.
    Samardzic T; Gerlach J; Muller K; Marinkovic D; Hess J; Nitschke L; Wirth T
    Eur J Immunol; 2002 Sep; 32(9):2481-9. PubMed ID: 12207332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Btk expression is controlled by Oct and BOB.1/OBF.1.
    Brunner C; Wirth T
    Nucleic Acids Res; 2006; 34(6):1807-15. PubMed ID: 16582106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myosin light chain 1 atrial isoform (MLC1A) is expressed in pre-B cells under control of the BOB.1/OBF.1 coactivator.
    Laumen H; Brunner C; Greiner A; Wirth T
    Nucleic Acids Res; 2004; 32(4):1577-83. PubMed ID: 15004244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes.
    Kim U; Qin XF; Gong S; Stevens S; Luo Y; Nussenzweig M; Roeder RG
    Nature; 1996 Oct; 383(6600):542-7. PubMed ID: 8849728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1/OCA-B/OBF1.
    Nielsen PJ; Georgiev O; Lorenz B; Schaffner W
    Eur J Immunol; 1996 Dec; 26(12):3214-8. PubMed ID: 8977324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation.
    Schubart DB; Rolink A; Kosco-Vilbois MH; Botteri F; Matthias P
    Nature; 1996 Oct; 383(6600):538-42. PubMed ID: 8849727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses.
    Brunner C; Sindrilaru A; Girkontaite I; Fischer KD; Sunderkötter C; Wirth T
    EMBO J; 2007 Jul; 26(13):3191-202. PubMed ID: 17568779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The OBF-1 gene locus confers B cell-specific transcription by restricting the ubiquitous activity of its promoter.
    Massa S; Junker S; Schubart K; Matthias G; Matthias P
    Eur J Immunol; 2003 Oct; 33(10):2864-74. PubMed ID: 14515270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-κB-dependent signals control BOB.1/OBF.1 and Oct2 transcriptional activity in B cells.
    Kilzheimer M; Quandt J; Langhans J; Weihrich P; Wirth T; Brunner C
    Eur J Immunol; 2015 Dec; 45(12):3441-53. PubMed ID: 26361887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1.
    Pfisterer P; Zwilling S; Hess J; Wirth T
    J Biol Chem; 1995 Dec; 270(50):29870-80. PubMed ID: 8530384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoid-specific transcription mediated by the conserved octamer site: who is doing what?
    Matthias P
    Semin Immunol; 1998 Apr; 10(2):155-63. PubMed ID: 9618761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell-specific transgenic expression of Bcl2 rescues early B lymphopoiesis but not B cell responses in BOB.1/OBF.1-deficient mice.
    Brunner C; Marinkovic D; Klein J; Samardzic T; Nitschke L; Wirth T
    J Exp Med; 2003 May; 197(9):1205-11. PubMed ID: 12732662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
    Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
    J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1.
    Schubart K; Massa S; Schubart D; Corcoran LM; Rolink AG; Matthias P
    Nat Immunol; 2001 Jan; 2(1):69-74. PubMed ID: 11135581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the aldehyde dehydrogenase 2-like gene is controlled by BOB.1/OBF.1 in B lymphocytes.
    Brunner C; Laumen H; Nielsen PJ; Kraut N; Wirth T
    J Biol Chem; 2003 Nov; 278(46):45231-9. PubMed ID: 12947107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octamer-dependent transcription in T cells is mediated by NFAT and NF-κB.
    Mueller K; Quandt J; Marienfeld RB; Weihrich P; Fiedler K; Claussnitzer M; Laumen H; Vaeth M; Berberich-Siebelt F; Serfling E; Wirth T; Brunner C
    Nucleic Acids Res; 2013 Feb; 41(4):2138-54. PubMed ID: 23293002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas.
    Sáez AI; Artiga MJ; Sánchez-Beato M; Sánchez-Verde L; García JF; Camacho FI; Franco R; Piris MA
    Mod Pathol; 2002 Mar; 15(3):211-20. PubMed ID: 11904338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of BOB.1/OBF.1 stability by SIAH.
    Boehm J; He Y; Greiner A; Staudt L; Wirth T
    EMBO J; 2001 Aug; 20(15):4153-62. PubMed ID: 11483518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.